Učitavanje...

Inhibition of Sodium-GlucoseCotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease

Background/Aims: Dapagliflozin (DAPA) is a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2) which induces glucosuria and osmotic diuresis. The therapeutic effect of DAPA in progressing stages of polycystic kidney disease (PKD) has not been studied. Methods: We examined the effect of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Daniel Rodriguez, Sarika Kapoor, Ilka Edenhofer, Stephan Segerer, Meliana Riwanto, Anja Kipar, Ming Yang, Changlin Mei, Rudolf P. Wüthrich
Format: Artigo
Jezik:Inglês
Izdano: Karger Publishers 2015-12-01
Serija:Kidney & Blood Pressure Research
Teme:
Online pristup:http://www.karger.com/Article/FullText/368540
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!